|
Originally published In Press as doi:10.1074/jbc.M202856200 on May 28, 2002
J. Biol. Chem., Vol. 277, Issue 32, 29101-29107, August 9, 2002
Temporal Separation of Vesicle Release from
Vesicle Fusion during Exocytosis*
Kevin P.
Troyer and
R. Mark
Wightman
From the Department of Chemistry, University of North Carolina at
Chapel Hill, Chapel Hill, North Carolina 27599
Received for publication, March 25, 2002, and in revised form, May 22, 2002
 |
ABSTRACT |
During exocytosis, vesicles in secretory cells
fuse with the cellular membrane and release their contents in a
Ca2+-dependent process. Release occurs
initially through a fusion pore, and its rate is limited by the
dissociation of the matrix-associated contents. To determine whether
this dissociation is promoted by osmotic forces, we have examined the
effects of elevated osmotic pressure on release and extrusion from
vesicles at mast and chromaffin cells. The identity of the molecules
released and the time course of extrusion were measured with fast scan
cyclic voltammetry at carbon fiber microelectrodes. In external
solutions of high osmolarity, release events following entry of
divalent ions (Ba2+ or Ca2+) were less
frequent. However, the vesicles appeared to be fused to the membrane
without extruding their contents, since the maximal observed
concentrations of events were less than 7% of those evoked in isotonic
media. Such an isolated, intermediate fusion state, which we term
"kiss-and-hold," was confirmed by immunohistochemistry at
chromaffin cells. Transient exposure of cells in the kiss and hold
state to isotonic solutions evoked massive release. These results
demonstrate that an osmotic gradient across the fusion pore is an
important driving force for exocytotic extrusion of granule contents
from secretory cells following fusion pore formation.
 |
INTRODUCTION |
Vesicles in secretory cells perform two different functions: they
are a storage depot for small molecules and they release these
molecules during exocytosis. Storage in dense core vesicles requires
stable packaging for an extended period of time. This is accomplished
by association of the vesicular contents. On the other hand, release
requires dissociation of this storage matrix on a relatively fast time
scale so the contents can be extruded (1, 2).
In mast cells, histamine and 5-HT are associated with a negatively
charged heparin matrix in the vesicles through a cation exchange type
of interaction (3). These vesicles contain 150 mM
histamine, which alone with its associated anion would lead to a free
osmolality of ~550 mosM (4). However, the vesicles are iso-osmotic with the 300-mosM cytoplasm because
of the association of the molecules within the granule matrix (5).
Similarly, a single chromaffin cell vesicle contains 550 mM
catecholamine along with 122 mM ATP, 17-30 mM
Ca2+, 5 mM Mg2+, 22 mM
ascorbate, and the acidic protein chromogranin A, leading to a total
soluble concentration of 750 mM (6). Again, molecular associations lead to a state (7, 8) that is iso-osmotic with the
cytoplasm (6). These close associations have been documented by nuclear
magnetic resonance in vesicles from both cell types (9, 10).
Upon cell stimulation, the vesicle contacts the plasma membrane and
forms a fusion pore, the dynamics and control of which have been
reviewed recently (11, 12). Capacitance and amperometry techniques have
indicated that a portion of the vesicular contents can be released
through this fusion pore (13, 14). Furthermore, at both mast and
chromaffin cells, patch-amperometry measurements reveal that the fusion
pore can exist for several milliseconds prior to full extrusion of
vesicle contents (15, 16). Following secretory vesicle-cell membrane
fusion in mast cells vesicular swelling occurs (17), which has been
attributed to the displacement of associated cations in the granule
with hydrated cations such as Na+ from the external
solution (18). This ion exchange mechanism, with its associated
hydration effects (19), has been hypothesized and experimentally
supported at several cell types as reviewed by Artalejo
et al. (20).
Theoretical considerations of this process have likened the extrusion
and swelling to a controlled explosion that drives full release of the
vesicular contents and dissociation of the vesicular matrix (18).
Amperometric recordings revealed that the time course of release is
longer than that expected for free diffusion (1), having a duration of
several milliseconds at chromaffin cells (21, 22), and even longer at
mast cells (23), consistent with a rate-limiting dissociation. The time
course of extrusion can be decreased by perturbing any of the physical
and chemical gradients that exist between the vesicle interior and the
extracellular environment. These include osmolarity, pH, and cation
concentration (24-26). For example, increasing the osmotic gradient by
lowering the extracellular solution osmolarity decreases the release
time course and increases the amount released, whereas high
extracellular osmolarity has the opposite effect (27). In the present
work, the effects of high osmolarity (using elevated NaCl) on secretory cells were evaluated in an attempt to freeze exocytotic events at the
step between fusion pore formation and extrusion of vesicle contents.
The results reported are consistent with such a state and reveal that
extrusion of the vesicular contents is a distinct step in the sequence
of events termed exocytosis.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture--
Bovine adrenal medullary cells, enriched in
either epinephrine or norepinephrine using a Renografin gradient, were
cultured as previously described and plated at a density of 3 × 105 cells/plate (28). Cells were used on days 3-7 after
culture. Murine peritoneal mast cells were cultured as described
previously (29). Cells were plated on 25-mm glass coverslips (Carolina Biological Supply, Burlington, NC) contained in 35-mm diameter tissue
culture plates (Falcon; Fisher Scientific).
Electrochemistry--
Carbon fiber microelectrodes for the
detection of released molecules were prepared as described (30).
Electrodes were backfilled with a 4 M potassium acetate,
150 mM KCl solution and calibrated using 4 µM
epinephrine, norepinephrine, and histamine and 1 µM serotonin. FSCV1 was
performed using locally written Labview software (National Instruments,
Austin, TX) with an EI-400 potentiostat (Cypress Systems, Lawrence, KS)
(31). Potentials were scanned from 200 mV to +1600 mV and back for
catecholamines and from +100 to +1400 mV and back for histamine and
serotonin (potentials versus a Ag/AgCl reference electrode,
Bioanalytical Systems, Lafayette, IN). A scan rate of 2000 V/s was used
with a 60-Hz repetition rate. Spike detection and analysis at the peak
oxidation potentials for the molecules of interest were performed (32),
and the resulting current spike amplitudes were converted to
concentration based on electrode calibrations.
Cell Experiments--
Individual cells were stimulated to
release by pressure ejection (Picospritzer; General Valve Corp.,
Fairfield, NJ) of 5 mM BaCl2 or 60 mM KCl (chromaffin cells), 0.5 µM A23187
(mast cells), or transient isotonic buffer solution (chromaffin and mast cells) from a micropipette placed 30 µm from the cell. The carbon fiber microelectrode was placed 1 µm from the cell membrane using a piezoelectric manipulator (PCS-1000, Burleigh Instruments, Fishers, NY) on the stage of an inverted microscope (Axiovert 35;
Zeiss, Thornwood, NY). Cells were rinsed with isotonic Tris-HCl buffer
at room temperature prior to experiment. For experiments in which
bathing buffer osmolarity was changed, glass coverslips containing the
cells were placed in a perfusion chamber positioned on the microscope.
Confocal Microscopy--
D H labeling was used to visualize
events associated with exocytosis at chromaffin cells. To measure
surface-bound D H, a measure of cell membrane-vesicle fusion, cells
were exposed to 5 mM Ba2+ for 2 min in Tris-HCl
buffer (no added Ca2+) in iso- or hypertonic buffer.
Control cells were incubated without Ba2+. The cells were
then fixed with a non-permeant protocol by quickly removing the bathing
solutions and replacing them with identical buffers containing 4%
p-formaldehyde at 4 °C for 20 min (33). The cells were
then rinsed twice with buffer, incubated with 0.2% bovine serum
albumin for 10 min, rinsed two more times, and incubated with mouse
anti-D H monoclonal antibody (1:300; Chemicon, Temecula, CA) for 45 min at 4 °C. To monitor D H retention on the surface, an identical
procedure was followed except the cells were incubated in iso- or
hypertonic buffer for 20 min following Ba2+ but before
fixation. To monitor vesicle recycling, the procedure was again
identical except the anti-D H antibody was present during the
exposure to Ba2+. These cells were fixed and permeabilized
with ethanol to allow visualization of endocytosed D H.
After rinsing, D H was visualized by incubating the cells with
Alexa-Fluor 568 goat anti-mouse IgG conjugate (1:1000, Molecular Probes, Eugene, OR). The coverslips containing the cells were washed
and mounted on microscope slides with Vectashield (Vector Labs,
Burlingame, CA). Images were acquired using a 100× oil immersion objective on a Leica-LCS confocal microscope (Leica Instruments, Exton,
PA). Analysis of images was performed using Scion Image software
(Frederick, MD).
Mast Cell Optical Imaging--
Visualization of release from
mast cells was enhanced with 50 µg/ml ruthenium red (29). Individual
cells in both iso-osmotic and elevated osmolarity buffers were
stimulated to release and monitored using a CCD camera (Sensys,
Photometrics, Tucson, AZ) through the microscope.
Reagents and Solutions--
All chemicals were obtained from
Sigma and used as received. A23187 was prepared by 1000-fold dilution
of a stock solution in Me2SO. Iso-osmotic buffer
contained 12.5 mM Tris-HCl, 150 mM NaCl, 4 mM KCl, 1.2 mM MgCl2, and 5 mM glucose). Hypertonic buffers were prepared by elevating
the NaCl concentration to 520 mM for chromaffin cells and
350 mM for mast cells. All solutions were prepared using
doubly distilled deionized water and adjusted to pH 7.4 by addition
of NaOH.
 |
RESULTS |
Mast Cells--
Following transient exposure (5 s) to the
Ca2+ ionophore A23187 in isotonic buffer (150 mM NaCl), mast cells exhibited frequent exocytotic release
events that were detected by cyclic voltammetry (Table
I), consistent with previous
reports. Every exocytotic event resulted in the simultaneous release of
5-HT and histamine (Fig. 1) that
each gave a distinct voltammetric peak (29). Each event was
characterized by a simultaneous increase in the concentrations of
5-HT and histamine followed by a more gradual returned to base line. Occasionally the exocytotic spikes were preceded by a foot-like event (29) in which a transient, steady-state, low concentration of the
amine was present (data not shown). Such events have been shown to be
due to secretion through the fusion pore (13).
View this table:
[in this window]
[in a new window]
|
Table I
Effects of elevated osmolarity buffer on release from peritoneal mast
cells.
Cmax is the maximal concentration of histamine
measured from each current spike. ISO, ISO buffer contained 150 mM NaCl.
|
|

View larger version (62K):
[in this window]
[in a new window]
|
Fig. 1.
Cyclic voltammetric monitoring of exocytosis
at a mast cell in isotonic solution (150 mM NaCl) and
hypertonic solution (350 mM NaCl). Left
panel, typical release from a mast cell exposed to A23187 in
isotonic solution. A different cell, in hypertonic solution, was
exposed to A23187 for 5 s during the first dashed box
(middle panel) and then exposed to isotonic solution for
10 s during the second dashed box (right
panel). Color plots: release events were monitored with background
subtracted, FSCV that allows a simultaneous view of serotonin and
histamine (29). The potential applied to the carbon fiber
microelectrode is plotted on the y axis (from +0.1 to +1.4
and back to +0.1 V versus a Ag/AgCl reference), while the
x axis is time. The current intensity is encoded in color as
indicated by the scale bar (note change in scale
bars). For serotonin, the oxidation is maximal at +0.7 V, and for
histamine oxidation is maximal at +1.3 V. Middle trace,
current arising from oxidation of histamine. Upper trace,
fura-2 monitoring of intracellular divalent ion concentration at a
different cell.
|
|
Mast cells displayed greater sensitivity to elevations in osmolarity
than chromaffin cells. Application of external solution with NaCl
concentrations of 520 mM, as used with chromaffin cells (see below), caused either complete inhibition of
Ca2+-evoked release events or rapid, spontaneous
degranulation. At a lower NaCl concentration (350 mM NaCl),
only a few cells degranulated spontaneously. However, for intact cells,
release was quite dramatically altered. Exposure to A23187 in
hypertonic medium containing Ca2+ still evoked spikes, but
their maximal concentration was ~1% of that evoked in isotonic
solution. Indeed, they resemble feet unaccompanied by spikes. The
frequency of spikes was also reduced (Table I). Spikes with large
concentrations could be obtained if the cells were subsequently exposed
to an isotonic puff for a transient (5 s) period 3 min after the
initial A23187 exposure (an example is shown in Fig. 1). After the
exposure to isotonic buffer, the spikes continued for as long as 5 min
at a frequency similar to that in isotonic buffer (Table I).
Since the average diameter of mast cell vesicles is 700 nm (29), the
degranulation that occurs during exocytosis can be observed with light
microscopy. In hypertonic medium, the mast cells shrank and
degranulation was not apparent upon application of A23187 (Fig.
2b). This was the case despite
the fact that the voltammetric results showed spikes of histamine and
5-HT (Fig. 1), albeit small ones. However, degranulation was
readily observed immediately after transient application of isotonic
buffer, and it continued for the time scale of the release detected
with voltammetry (Fig. 2, c and d).

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 2.
Optical micrographs of a mast cell during
degranulation. a, initial view of the cell in
hypertonic solution (350 mM NaCl). b, cell
following exposure to A23187. c, same cell following
subsequent exposure (10 s) to isotonic solution (150 mM
NaCl). d, five minutes after c.
|
|
The lack of visual degranulation is not due to failure of
Ca2+ to enter the cell. Ca2+ entry was
immediate upon exposure to A23187 in hypertonic buffer as revealed by
fluorescence from fura-2, the ratiometric divalent ion indicator (34).
Furthermore, upon exposure to isotonic buffer, the larger spikes, with
their accompanying visual degranulation, were not accompanied by a
further influx of Ca2+ (Fig. 1, upper trace).
Thus, in hypertonic solution, it appears that Ca2+ entry
evokes vesicle-cell membrane fusion, but extrusion of vesicular contents is suppressed unless isotonic conditions are restored for a
transient period.
Chromaffin Cells--
In isotonic solution without
Ca2+, transient exposure of chromaffin cells to
Ba2+ (5 mM, 5 s) causes exocytotic release
of catecholamines (Fig. 3) (24). In
isotonic solution containing Ca2+, transient exposure of
chromaffin cells to elevated KCl (60 mM, 5 s) also
causes exocytotic release of catecholamines (Fig.
4) (35). Cyclic voltammetry can be used
to monitor the release and can distinguish cells that secrete
norepinephrine from those that secrete epinephrine (36). Cyclic
voltammograms (37) also reveal that the foot present for many
exocytotic events is comprised of catecholamines (data not shown).
Release evoked by the two secretagogues is quite similar (24) (Table
II).

View larger version (69K):
[in this window]
[in a new window]
|
Fig. 3.
Cyclic voltammetric monitoring of exocytosis
at a chromaffin cell in isotonic (150 mM NaCl) and
hypertonic solution (520 mM NaCl). Left
panel, release from a cell in isotonic solution upon exposure to
Ba2+. The cell in hypertonic solution (middle
panel) was exposed to Ba2+ for 5 s during the
first dashed box and then exposed to isotonic solution for
15 s during the second dashed box (right
panel). Color plots: release events were monitored with FSCV. The
potential applied to the carbon fiber microelectrode is plotted on the
y axis, while the x axis is time. The current
intensity is encoded in color as indicated by the scale bar
(note change in scale bars). For epinephrine, oxidation of
the catechol to its o-quinone occurs at +0.75 V with a
second peak at +1.5 V from the oxidation of the secondary amine as
described previously (36). Middle trace, current arising
from oxidation of epinephrine at +0.75 V. Upper trace,
fura-2 monitoring of intracellular divalent ion concentration at a
different cell.
|
|

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 4.
Cyclic voltammetric monitoring of exocytosis
at a chromaffin cell in isotonic (150 mM NaCl) and
hypertonic solution (520 mM NaCl). Left
panel, release from a cell exposed to 60 mM
K+ in isotonic solution. The cell in hypertonic solution
was exposed to K+ for 5 s during the first
dashed box (middle panel) and then exposed to
isotonic solution for 15 s during the second dashed box
(right panel). Color plots: release events were monitored
with FSCV. The current intensity is encoded in color as indicated by
the scale bar (note change in scale bars).
Middle trace, current arising from oxidation of epinephrine
at +0.75 V. The experimental parameters are the same as those in Fig.
3. Upper trace, fura-2 monitoring of intracellular divalent
ion concentration at a different cell.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Effects of elevated osmolarity buffer on release from chromaffin cells
stimulated with 5 mM Ba2+ or 60 mM
K+.
Cmax values are measured from catecholamine
oxidative peak. ISO, ISO buffer contained 150 mM NaCl.
|
|
In hyperosmotic solutions (520 mM NaCl) without
Ca2+, transient exposure to 5 mM
Ba2+ also results in exocytotic spikes from chromaffin
cells (Fig. 3), but they are less frequent and much smaller in
amplitude (Table II). Similar results are obtained for
K+-induced release in hypertonic solutions (Fig. 4, Table
II). The maximal concentration of spikes in hypertonic medium with
Ba2+ is only 7% and with K+ is only 10% of
that seen in isotonic medium. In all cases the cyclic voltammograms
revealed that the small, foot-like events were the same catecholamine
that the cell normally secreted. Thus, the results at chromaffin cells
are quite similar to those at mast cells: in hyperosmotic solutions,
release events of small amplitude can be evoked, but their
concentration and frequency is lower than in isotonic solution.
Transient application of an isotonic solution to chromaffin cells for
15 s at 2 min after exposure to either secretagogue in hypertonic
medium induced massive release (Table II, Figs. 3 and 4). In 27%
of the chromaffin cells pretreated with 60 mM KCl and 36%
of the cells pretreated with Ba2+, this release consisted
of one to two spikes with maximal concentrations greater than 40 µM that appeared to be compound exocytotic events. In the
remainder of cells, spikes were observed shortly after exposure to
isotonic buffer with a delay time of ~4 s to the first spike. The
isotonic buffer caused cell swelling on a similar time scale. The large
spikes diminished immediately following cessation of transient exposure
to isotonic buffer. When cells were completely restored to isotonic
conditions, exposure to either secretagogue evoked spikes with a normal
frequency and maximal concentrations (data not shown).
Fura-2 was used to monitor either intracellular Ba2+ or
Ca2+ in these experiments. It is well established in
isotonic solutions that both secretagogues cause an immediate increase
in intracellular divalent ions (34), and this was replicated in this
work (data not shown). In hypertonic solutions, pressure ejection of
Ba2+ or K+ similarly caused an elevation in
intracellular divalent ion concentrations. In the case of
Ba2+, the signal remained elevated for greater than 3 min
(Fig. 3) because intracellular Ca2+ stores do not
effectively sequester it (38). Following K+ in hypertonic
solution, the divalent ion signal returned to base-line levels ~10 s
after its application. Thus, the observed, divalent ion entry
accompanies the small release events obtained in hypertonic solutions.
Fura-2 measurements were also made during reintroduction of isotonic
solution after exposure to secretagogues. The accompanying cell
swelling and dye dilution complicates interpretation of the changes in
divalent ions. There was no observable change in the bound to free
ratio at cells that had been exposed to Ba2+; however,
results in cells that had been exposed to K+ were equivocal.
Confocal Microscopy--
To provide evidence that vesicles fused
with the plasma membrane in hypertonic solution, a fluorescently
labeled antibody to D H was employed. D H is a vesicular enzyme
that appears on the surface of chromaffin cells following exocytosis
(39). Exposure to Ba2+ for 2 min in either isotonic (Fig.
5a) or hypertonic solutions (Fig. 5b) causes D H localization on the cell perimeter.
The fluorescence at the cell surface, which is eight times more intense
in cells stimulated in isotonic solution, indicates vesicle-cell
membrane fusion has occurred under both conditions, exposing the
vesicle interior to the external solution. In both solutions,
unstimulated cells showed no fluorescence (data not shown).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 5.
Confocal images of chromaffin cells
stimulated to release under different conditions and stained with
D H antibody. a,
c, and e, results obtained in isotonic solution.
b, d, and f, results obtained in
hypertonic (520 mM NaCl) solution. a and
b, cell was fixed after 2-min exposure to 5 mM
Ba2+ followed by D H antibody staining. c and
d, cells were exposed to Ba2+ as in a
and rinsed for 20 min without Ba2+ before fixation and
staining. e and f, cells were stimulated as in
a but in the presence of anti-D H antibody to reveal
endocytosis.
|
|
A similar experiment was used to test vesicle lifetime at the cell
surface. With the same treatment as in Fig. 5a, but with a
20-min incubation in buffer before the addition of D H antibody, D H was not found on cell surfaces when stimulated in isotonic medium
(Fig. 5c). This is consistent with vesicle endocytosis that
occurs on a time scale much shorter than 20 min in isotonic solutions
(40). Supporting this conclusion, fluorescence was found within cells
that were stimulated to release in isotonic solutions in the presence
of D H antibody (Fig. 5e). In contrast, D H antibody was
present on cell surfaces stimulated in hypertonic medium under all
conditions, but was not seen to incorporate within the cell (Fig. 5,
d and f). The rate of endocytosis is known to be
lower in hypertonic solutions, consistent with this finding (41).
 |
DISCUSSION |
In high osmolarity solutions, secretion from both mast and
chromaffin cells is dramatically altered. The results presented here
show that vesicle-cell membrane fusion can still occur under these
conditions, but that full extrusion of the vesicle contents does not
occur. Indeed, the fused vesicles in hypertonic solution appear to be
frozen at the cell surface, and only release after swelling of the
vesicle matrix is allowed to occur. Previous studies have demonstrated
that both chromaffin and mast cell vesicles contract in response to
hypertonic stress without disruption of their stored contents (5).
Indeed, the chromaffin vesicle has been termed an ideal osmometer
between 300 and 1000 mosM (6). The new finding of
this work is that high osmolarity solutions prevent full extrusion of
vesicle contents and allow temporal isolation of an intermediate state
in the sequence of events that occur during exocytosis, a state we
refer to as "kiss-and-hold."
Hypertonic solutions clearly lower the rate of exocytosis at both mast
and chromaffin cells. This could arise from an increase in actin
filaments at the cell membrane as found in neutrophils in hyperosmotic
solutions (42), because the rate of exocytosis in chromaffin cells
depends on the degree of association of actin filaments (43). However,
previous visual studies in high osmolarity solutions have shown that
vesicle-cell membrane fusion is not prevented at chromaffin or mast
cells (17, 44, 45), nor in sea urchin eggs (46). In this work,
vesicle-cell membrane fusion is established in chromaffin cells by the
presence of D H on the cell surface in both isotonic and hypertonic
medium. D H labeling is lowered in hypertonic solutions, correlating
well with the decreased frequency of electrochemically detected spikes. At mast cells, visual evidence for vesicle-cell membrane fusion was not
obtained in hypertonic medium, although secretion was clearly evident
by the cyclic voltammetry. The secretory events that are seen are so
small that they resemble the feet that precede some exocytotic events
in iso-osmolar solutions at both types of cells in hypertonic media.
This is the expected outcome if vesicle fusion occurred in hypertonic
solutions with only minor extrusion of the contents. Despite their
small size, the cyclic voltammograms establish that the substances
detected are those stored in the vesicles.
All of the evidence from both cell types indicates that the small size
of the spikes obtained in hypertonic medium is a consequence of
inhibition of vesicle-matrix dissociation. The association of the
vesicle contents in chromaffin cells has been characterized as a
"dynamic viscous solution that is stabilized by ternary complex formation" (10) and is also well documented in mast cells (47). Upon
exposure to the extracellular solution through the fusion pore, at the
initial "kiss," exchange between the vesicular interior and the
extracellular fluid begins. Normally the matrix dissociation and
extrusion of its contents relies on hydration, with its accompanying matrix swelling, that is driven by a physical or chemical gradient across the fusion pore. By removing the osmotic gradient in hypertonic solutions, one of the driving forces for dissociation and extrusion is
dissipated. The small amount of secretion that does occur could arise
from components originally in an unassociated state or a small amount
of matrix dissociation that occurs at the fusion pore, but which is
unable to propagate into the remainder of the vesicle. Because rates of
endocytosis are lowered in hypertonic solutions, the fused, intact
vesicle "holds" at the cell surface for an extended period of time.
The frozen, fused vesicle state established in hypertonic medium is
destroyed once the osmotic gradient is re-established. This occurs with
the transient isotonic exposure that evokes multiple spikes on the time
scale of cellular swelling. In mast cells, the maximal concentration of
these spikes is consistent with extrusion of contents from previously
fused vesicles. At chromaffin cells, the maximal concentration and time
course of some observed spikes are larger than under normal exocytotic
conditions, consistent with multiple, simultaneous secretory events.
For cells stimulated with K+, the original stimulus is no
longer present upon isotonic solution exposure, and yet secretion is
still observed. This strongly suggests that the observed spikes arise
from previously fused vesicles. With Ba2+ at chromaffin
cells and with mast cells, the isotonic-evoked spikes are unaccompanied
by an increase in intracellular divalent ions. Thus, it is clear that
the discrete processes of vesicle fusion and vesicle extrusion have
been temporally separated. Concentration and pH gradients between the
vesicle matrix and the external solution may exert similar effects (24,
25). Indeed, chromaffin cells previously stimulated with
Ba2+ in hypertonic solutions did not release when exposed
to isotonic buffer at pH 5.5 (data not shown). Thus, re-establishing an
osmotic gradient is not sufficient to unravel the kiss and hold state; the pH gradient is necessary as well.
All of these results are consistent with recent mathematical models for
the swelling of secretory granules after fusion pore formation and its
role in extrusion of granule contents (18, 48). These models indicate
that the hydration and swelling of the vesicle matrix cause an
enlargement of the fusion pore leading to its destabilization. Thus,
normally in mast and chromaffin cells the pore expansion of the vesicle
occurs rapidly, driven by the irreversible swelling of the matrix, and
results in full incorporation of the vesicle membrane and extrusion of
vesicular contents as illustrated in the sequence of steps in Fig.
6. By removing the driving force for
swelling, we were able to isolate the intermediate kiss-and-hold
state. The mathematical models predict that "kiss-and-run" events,
events where fusion pore formation allows escape of some transmitter
followed by vesicular retreat from the cellular membrane without fully
fusing, are unlikely under normal conditions at cells with large
vesicles. Consistent with these models, all fusion pore events in mast
cells are followed by complete fusion of the vesicle with the cellular
membrane and subsequent release (15). Patch-amperometry studies on
chromaffin cells reveal only 10% of the observed fusion events are
kiss-and-run (16), but these occurrences are increased with elevated
external Ca2+ concentrations (49). In the absence of
endocytosis caused by elevated osmolarity, one would expect these
events to be restricted to the cell membrane, as shown in this work,
until acted upon by external forces. For small vesicles, the force of
matrix expansion is insufficient to destabilize the fusion pore, and
kiss-and-run is more likely. This has also been observed for small
clear vesicles at hippocampal synapses (50).

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 6.
Model for separation of vesicle fusion and
subsequent extrusion of contents. When stimulated in hypertonic
solution, vesicles dock with the plasma membrane and unassociated
contents can diffuse through the fusion pore (upper).
Subsequent exposure to isotonic solution causes expansion of the
vesicle matrix and extrusion of contents (lower).
|
|
The hypertonically constructed kiss-and-hold configuration inhibits the
dissociation of matrix constituents following vesicle fusion with the
cell membrane. This provides access to the vesicle interior while
maintaining the viability of the cell, which may allow for a more
complete understanding of the complex interaction of molecules within
the vesicle matrix in their natural environment as well as a glimpse of
their dissociation during exocytosis. Under normal physiological
conditions, full fusion and extrusion of vesicular contents is
predominant at both mast and chromaffin cells, relying on the
destabilization of the granule matrix through swelling to rapidly pass
through the kiss-and-hold state.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 919-962-1472;
Fax: 919-962-2388; E-mail: rmw@unc.edu.
Published, JBC Papers in Press, May 28, 2002, DOI 10.1074/jbc.M202856200
 |
ABBREVIATIONS |
The abbreviations used are:
FSCV, fast scan
cyclic voltammetry;
D H, dopamine- -hydroxylase;
5-HT, 5-hydroxytryptamine.
 |
REFERENCES |
| 1.
|
Schroeder, T. J.,
Borges, R.,
Finnegan, J. M.,
Pihel, K.,
Amatore, C.,
and Wightman, R. M.
(1996)
Biophys. J.
70,
1061-1068[Medline]
[Order article via Infotrieve]
|
| 2.
|
Marszalek, P. E.,
Farrell, B.,
Verdugo, P.,
and Fernandez, J. M.
(1997)
Biophys. J.
73,
1169-1183[Medline]
[Order article via Infotrieve]
|
| 3.
|
Uvnas, B.,
and Aborg, C. H.
(1984)
Acta Physiol. Scand.
120,
99-107[Medline]
[Order article via Infotrieve]
|
| 4.
|
Fernandez, J. M.,
Villalon, M.,
and Verdugo, P.
(1991)
Biophys. J.
59,
1022-1027[Medline]
[Order article via Infotrieve]
|
| 5.
|
Brodwick, M. S.,
Curran, M.,
and Edwards, C.
(1992)
J. Membr. Biol.
126,
159-169[Medline]
[Order article via Infotrieve]
|
| 6.
|
Holz, R. W.
(1986)
Annu. Rev. Physiol.
48,
175-189[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Helle, K. B.,
Reed, R. K.,
Pihl, K. E.,
and Serck-Hanssen, G.
(1985)
Acta Physiol. Scand.
123,
21-33[Medline]
[Order article via Infotrieve]
|
| 8.
|
Yoo, S. H.,
and Lewis, M. S.
(1992)
J. Biol. Chem.
267,
11236-11241[Abstract/Free Full Text]
|
| 9.
|
Rabenstein, D. L.,
Ludowyke, R.,
and Lagunoff, D.
(1987)
Biochemistry
26,
6923-6926[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Daniels, A. J.,
Williams, R. J.,
and Wright, P. E.
(1978)
Neuroscience
3,
573-585[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Zimmerberg, J.,
and Chernomordik, L. V.
(1999)
Adv. Drug Deliv. Rev.
38,
197-205[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Oheim, M.,
and Stuhmer, W.
(2000)
Eur. Biophys. J.
29,
67-89[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Breckenridge, L. J.,
and Almers, W.
(1987)
Nature
328,
814-817[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Neher, E.
(1993)
Nature
363,
497-498[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Alvarez, d. T.,
Fernandez-Chacon, R.,
and Fernandez, J. M.
(1993)
Nature
363,
554-558[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Albillos, A.,
Dernick, G.,
Horstmann, H.,
Almers, W.,
Alvarez, d. T.,
and Lindau, M.
(1997)
Nature
389,
509-512[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Zimmerberg, J.,
Curran, M.,
Cohen, F. S.,
and Brodwick, M.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
1585-1589[Abstract/Free Full Text]
|
| 18.
|
Amatore, C.,
Bouret, Y.,
Travis, E. R.,
and Wightman, R. M.
(2000)
Biochimie (Paris)
82,
481-496[Medline]
[Order article via Infotrieve]
|
| 19.
|
Verdugo, P.
(1991)
Am. Rev. Respir. Dis.
144,
S33-S37[Medline]
[Order article via Infotrieve]
|
| 20.
|
Artalejo, C. R.,
Elhamdani, A.,
and Palfrey, H. C.
(1998)
Curr. Biol.
8,
R62-R65[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Walker, A.,
Glavinovic, M. I.,
and Trifaro, J. M.
(1996)
Pfluegers Arch.
431,
729-735[Medline]
[Order article via Infotrieve]
|
| 22.
|
Wightman, R. M.,
Jankowski, J. A.,
Kennedy, R. T.,
Kawagoe, K. T.,
Schroeder, T. J.,
Leszczyszyn, D. J.,
Near, J. A.,
Diliberto, E. J., Jr.,
and Viveros, O. H.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
10754-10758[Abstract/Free Full Text]
|
| 23.
|
Marszalek, P. E.,
Farrell, B.,
Verdugo, P.,
and Fernandez, J. M.
(1997)
Biophys. J.
73,
1160-1168[Medline]
[Order article via Infotrieve]
|
| 24.
|
Jankowski, J. A.,
Finnegan, J. M.,
and Wightman, R. M.
(1994)
J. Neurochem.
63,
1739-1747[Medline]
[Order article via Infotrieve]
|
| 25.
|
Jankowski, J. A.,
Schroeder, T. J.,
Ciolkowski, E. L.,
and Wightman, R. M.
(1993)
J. Biol. Chem.
268,
14694-14700[Abstract/Free Full Text]
|
| 26.
|
Pihel, K.,
Travis, E. R.,
Borges, R.,
and Wightman, R. M.
(1996)
Biophys. J.
71,
1633-1640[Medline]
[Order article via Infotrieve]
|
| 27.
|
Borges, R.,
Travis, E. R.,
Hochstetler, S. E.,
and Wightman, R. M.
(1997)
J. Biol. Chem.
272,
8325-8331[Abstract/Free Full Text]
|
| 28.
|
Leszczyszyn, D. J.,
Jankowski, J. A.,
Viveros, O. H.,
Diliberto, E. J., Jr.,
Near, J. A.,
and Wightman, R. M.
(1991)
J. Neurochem.
56,
1855-1863[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Travis, E. R.,
Wang, Y. M.,
Michael, D. J.,
Caron, M. G.,
and Wightman, R. M.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
162-167[Abstract/Free Full Text]
|
| 30.
|
Kawagoe, K. T.,
Zimmerman, J. B.,
and Wightman, R. M.
(1993)
J. Neurosci. Methods
48,
225-240[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Michael, D. J.,
Joseph, J. D.,
Kilpatrick, M. R.,
Travis, E. R.,
and Wightman, R. M.
(1999)
Anal. Chem.
71,
3941-3947[Medline]
[Order article via Infotrieve]
|
| 32.
|
Segura, F.,
Brioso, M. A.,
Gomez, J. F.,
Machado, J. D.,
and Borges, R.
(2000)
J. Neurosci. Methods
103,
151-156[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Cuchillo-Ibanez, I.,
Michelena, P.,
Albillos, A.,
and Garcia, A. G.
(1999)
FEBS Lett.
459,
22-26[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Neher, E.
(1995)
Neuropharmacology
34,
1423-1442[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Finnegan, J. M.,
and Wightman, R. M.
(1995)
J. Biol. Chem.
270,
5353-5359[Abstract/Free Full Text]
|
| 36.
|
Pihel, K.,
Schroeder, T. J.,
and Wightman, R. M.
(1994)
Anal. Chem.
66,
4532-4537[CrossRef]
|
| 37.
|
Wightman, R. M.,
Schroeder, T. J.,
Finnegan, J. M.,
Ciolkowski, E. L.,
and Pihel, K.
(1995)
Biophys. J.
68,
383-390[Medline]
[Order article via Infotrieve]
|
| 38.
|
von Ruden, L.,
Garcia, A. G.,
and Lopez, M. G.
(1993)
FEBS Lett.
336,
48-52[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Wick, P. F.,
Trenkle, J. M.,
and Holz, R. W.
(1997)
Neuroscience
80,
847-860[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Palfrey, H. C.,
and Artalejo, C. R.
(1998)
Neuroscience
83,
969-989[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
von Grafenstein, H.,
Roberts, C. S.,
and Baker, P. F.
(1986)
J. Cell Biol.
103,
2343-2352[Abstract/Free Full Text]
|
| 42.
|
Rizoli, S. B.,
Rotstein, O. D.,
Parodo, J.,
Phillips, M. J.,
and Kapus, A.
(2000)
Am. J. Physiol.
279,
C619-C633[Abstract/Free Full Text]
|
| 43.
|
Vitale, M. L.,
Seward, E. P.,
and Trifaro, J. M.
(1995)
Neuron
14,
353-363[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Breckenridge, L. J.,
and Almers, W.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
1945-1949[Abstract/Free Full Text]
|
| 45.
|
Holz, R. W.,
and Senter, R. A.
(1986)
J. Neurochem.
46,
1835-1842[Medline]
[Order article via Infotrieve]
|
| 46.
|
Whitaker, M.,
and Zimmerberg, J.
(1987)
J. Physiol.
389,
527-539[Abstract/Free Full Text]
|
| 47.
|
Uvnas, B.
(1991)
J. Physiol Pharmacol.
42,
211-219[Medline]
[Order article via Infotrieve]
|
| 48.
|
Chizmadzhev, Y. A.,
Kuzmin, P. I.,
Kumenko, D. A.,
Zimmerberg, J.,
and Cohen, F. S.
(2000)
Biophys. J.
78,
2241-2256[Medline]
[Order article via Infotrieve]
|
| 49.
|
Ales, E.,
Tabares, L.,
Poyato, J. M.,
Valero, V.,
Lindau, M.,
and Alvarez, d. T.
(1999)
Nat. Cell Biol.
1,
40-44[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Stevens, C. F.,
and Williams, J. H.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
12828-12833[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. V. Harper, J. A. Cummerson, M. R. H. White, S. J. Publicover, and P. M. Johnson
Dynamic resolution of acrosomal exocytosis in human sperm
J. Cell Sci.,
July 1, 2008;
121(13):
2130 - 2135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Wightman
Detection technologies. Probing cellular chemistry in biological systems with microelectrodes.
Science,
March 17, 2006;
311(5767):
1570 - 1574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Ashton and Y. A. Ushkaryov
Properties of Synaptic Vesicle Pools in Mature Central Nerve Terminals
J. Biol. Chem.,
November 4, 2005;
280(44):
37278 - 37288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chattopadhyay, P. Sun, P. Wang, B. Abonyo, N. L. Cross, and L. Liu
Fusion of Lamellar Body with Plasma Membrane Is Driven by the Dual Action of Annexin II Tetramer and Arachidonic Acid
J. Biol. Chem.,
October 10, 2003;
278(41):
39675 - 39683.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|